in this issue
Regions :: Western Europe :: Sweden
Cambrex and Dow open facility in Sweden for producing Dow’s HPMCAS products
October 30, 2013 | Deepti Ramesh
Cambrex (East Rutherford, NJ) and Dow Chemical say they have opened a previously announced new facility at the Cambrex Karlskoga (Karlskoga, Sweden) site for manufacturing Dow’s hydroxypropyl methylcellulose acetate succinate (HPMCAS) for drug solubility enhancement. Cambrex and Dow, earlier this year, executed an agreement for Cambrex to contract manufacture Dow’s HPMCAS, and, as part of this agreement, the new plant was constructed at Karlskoga. The facility completion and start of the HPMCAS product validation marks a year-long journey that began...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee